Gait robot-assisted rehabilitation in persons with spinal cord injury: A scoping review.


Journal

NeuroRehabilitation
ISSN: 1878-6448
Titre abrégé: NeuroRehabilitation
Pays: Netherlands
ID NLM: 9113791

Informations de publication

Date de publication:
2022
Historique:
pubmed: 12 12 2022
medline: 11 1 2023
entrez: 11 12 2022
Statut: ppublish

Résumé

Many robots are available for gait rehabilitation (BWSTRT and ORET) and their application in persons with SCI allowed an improvement of walking function. The aim of the study is to compare the effects of different robotic exoskeletons gait training in persons with different SCI level and severity. Sixty-two studies were included in this systematic review; the study quality was assessed according to GRADE and PEDro's scale. Quality assessment of included studies (n = 62) demonstrated a prevalence of evidence level 2; the quality of the studies was higher for BWSTRT (excellent and good) than for ORET (fair and good). Almost all persons recruited for BWSTRT had an incomplete SCI; both complete and incomplete SCI were recruited for ORET. The SCI lesion level in the persons recruited for BWSTRT are from cervical to sacral; mainly from thoracic to sacral for ORET; a high representation of AIS D lesion resulted both for BWSTRT (30%) and for ORET (45%). The walking performance, tested with 10MWT, 6MWT, TUG and WISCI, improved after exoskeleton training in persons with incomplete SCI lesions, when at least 20 sessions were applied. Persons with complete SCI lesions improved the dexterity in walking with exoskeleton, but did not recover independent walking function; symptoms such as spasticity, pain and cardiovascular endurance improved. Different exoskeletons are available for walking rehabilitation in persons with SCI. The choice about the kind of robotic gait training should be addressed on the basis of the lesion severity and the possible comorbidities.

Sections du résumé

BACKGROUND BACKGROUND
Many robots are available for gait rehabilitation (BWSTRT and ORET) and their application in persons with SCI allowed an improvement of walking function.
OBJECTIVE OBJECTIVE
The aim of the study is to compare the effects of different robotic exoskeletons gait training in persons with different SCI level and severity.
METHODS METHODS
Sixty-two studies were included in this systematic review; the study quality was assessed according to GRADE and PEDro's scale.
RESULTS RESULTS
Quality assessment of included studies (n = 62) demonstrated a prevalence of evidence level 2; the quality of the studies was higher for BWSTRT (excellent and good) than for ORET (fair and good). Almost all persons recruited for BWSTRT had an incomplete SCI; both complete and incomplete SCI were recruited for ORET. The SCI lesion level in the persons recruited for BWSTRT are from cervical to sacral; mainly from thoracic to sacral for ORET; a high representation of AIS D lesion resulted both for BWSTRT (30%) and for ORET (45%). The walking performance, tested with 10MWT, 6MWT, TUG and WISCI, improved after exoskeleton training in persons with incomplete SCI lesions, when at least 20 sessions were applied. Persons with complete SCI lesions improved the dexterity in walking with exoskeleton, but did not recover independent walking function; symptoms such as spasticity, pain and cardiovascular endurance improved.
CONCLUSION CONCLUSIONS
Different exoskeletons are available for walking rehabilitation in persons with SCI. The choice about the kind of robotic gait training should be addressed on the basis of the lesion severity and the possible comorbidities.

Identifiants

pubmed: 36502343
pii: NRE220061
doi: 10.3233/NRE-220061
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

609-647

Auteurs

Giulia Stampacchia (G)

Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Valeria Gazzotti (V)

Centro Protesi Vigorso di Budrio, Istituto Nazionale Assicurazione Infortuni sul Lavoro (INAIL), Bologna, Italy.

Matteo Olivieri (M)

Scuola IMT Alti Studi di Lucca, Lucca, Italy.

Elisa Andrenelli (E)

Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.

Donatella Bonaiuti (D)

Piero Redaelli Geriatric Institute, Milan, Italy.

Rocco Salvatore Calabro (RS)

IRCCS Centro Neurolesi "Bonino Pulejo", Messina, Italy.

Simona Maria Carmignano (SM)

Rehabilitation Therapeutic Center (CTR), Potenza, Italy.
University of Salerno, Salerno, Italy.

Anna Cassio (A)

Spinal Cord Unit and Intensive Rehabilitation Medicine, Ospedale di Fiorenzuola d'Arda, AUSL Piacenza, Piacenza, Italy.

Cira Fundaro (C)

Neurophysiopathology Unit, Istituti Clinici Scientifici Maugeri, IRCCS Montescano, Pavia, Italy.

Isabella Companini (I)

Department of Neuromotor and Rehabilitation, LAM-Motion Analysis Laboratory, San Sebastiano Hospital, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

David Mazzoli (D)

Gait and Motion Analysis Laboratory, Sol et Salus Ospedale Privato Accreditato, Rimini, Italy.

Simona Cerulli (S)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Carmelo Chisari (C)

Department of Translational Research and New Technologies in Medicine and Surgery, Neurorehabiltation Section, University of Pisa, Pisa, Italy.

Valentina Colombo (V)

Montecatone Rehabilitation Institute, Imola, Italy.

Stefania Dalise (S)

Department of Translational Research and New Technologies in Medicine and Surgery, Neurorehabiltation Section, University of Pisa, Pisa, Italy.

Daniele Mazzoleni (D)

School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Corrado Melegari (C)

Elias Neuroriabilitazione, Parma, Italy.

Andrea Merlo (A)

Gait and Motion Analysis Laboratory, Sol et Salus Ospedale Privato Accreditato, Rimini, Italy.

Paolo Boldrini (P)

Italian Society of Physical Medicine and Rehabilitation (SIMFER), Rome, Italy.

Stefano Mazzoleni (S)

Department of Electrical and Information Engineering, Politecnico di Bari, Bari, Italy.

Federico Posteraro (F)

Department of Rehabilitation, Versilia Hospital - AUSL12, Viareggio, Italy.

Miriam Mazzucchelli (M)

School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Paolo Benanti (P)

Pontifical Gregorian University, Rome, Italy.

Enrico Castelli (E)

Department of Paediatric Neurorehabilitation, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Francesco Draicchio (F)

Department of Occupational and Environmental Medicine Epidemiology and Hygiene, INAIL, Rome, Italy.

Vincenzo Falabella (V)

Italian Federation of Persons with Spinal Cord Injuries (FAIP Onlus), Rome, Italy.

Silvia Galeri (S)

IRCCS Fondazione Don Carlo Gnocchi, Pavia, Italy.

Francesca Gimigliano (F)

Department of Mental, Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Mauro Grigioni (M)

National Center for Innovative Technologies in Public Health, Italian National Institute of Health, Rome, Italy.

Stefano Mazzon (S)

Rehabilitation Unit, ULSS (Local Health Authority) Euganea, Camposampiero Hospital, Padua, Italy.

Franco Molteni (F)

Department of Rehabilitation Medicine, Villa Beretta Rehabilitation Center, Valduce Hospital, Lecco, Italy.

Giovanni Morone (G)

IRCCS Santa Lucia Foundation, Rome, Italy.

Maurizio Petrarca (M)

Movement Analysis and Robotics Laboratory (MARlab), IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

Alessandro Picelli (A)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Michele Senatore (M)

Associazione Italiana dei Terapisti Occupazionali (AITO), Rome, Italy.

Giuseppe Turchetti (G)

Institute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.

Emiliana Bizzarrini (E)

Department of Rehabilitation Medicine, Spinal Cord Unit, Gervasutta Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH